FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Inquirer on MSN44m
US approves first-ever obstructive sleep apnea drug
On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...
Study suggests estrogen may trigger binge drinking
The female hormone estrogen appears to promote binge drinking in women, a new mouse study published recently in the journal ...